What is CJC-1295 No DAC
Global Peptide Sciences supplies CJC 1295 No DAC, a short-acting growth hormone–releasing hormone (GHRH) analogue designed for controlled laboratory research. This version is commonly selected for studies focused on natural growth hormone pulse patterns and endocrine signalling.
If you are looking to buy CJC 1295 No DAC online in Australia, our lab-grade peptide is third-party tested and supplied with full Certificate of Analysis (COA) documentation.
What is CJC-1295 No DAC
CJC 1295 No DAC is a shorter-acting version of the CJC-1295 peptide. Unlike the DAC version, this formulation has a much shorter half-life, allowing researchers to study more precise growth hormone pulse activity in experimental models.
Because it clears more quickly, many laboratory protocols prefer CJC 1295 No DAC when examining natural GH rhythm studies rather than sustained release patterns.
CJC 1295 No DAC Peptide Benefits in Research
CJC 1295 No DAC peptide benefits are commonly explored in controlled research environments investigating:
- Enhances natural GH pulse frequency
- Promotes lean muscle and fat burning
- Short-acting, ideal for precise timing
- Lowers risk of GH desensitization
These observations refer strictly to laboratory and research applications.
Why Choose CJC 1295 No DAC?
Researchers often select CJC 1295 No DAC due to:
- Short-acting profile for controlled timing studies
- More natural GH pulse research patterns
- Greater flexibility in experimental protocols
- Clear distinction from long-acting DAC versions
This makes it a preferred choice in research models requiring precise hormonal signalling investigations.
Buy CJC 1295 No DAC Peptide in Australia
If you want to buy CJC 1295 No DAC peptide, Global Peptide Sciences offers lab-grade injectable peptides with verified purity and third-party testing.
You can securely buy CJC 1295 No DAC online in Australia, with fast nationwide shipping and full COA documentation included with every batch.
All products are supplied strictly for research use only.
Research Applications
GH Pulse & Endocrine Rhythm Research
CJC-1295 No DAC is studied for:
- Short, natural GH pulse stimulation
- GHRH receptor activation pathways
- GH frequency and rhythm modeling without long half-life carryover
Body Composition & Recovery
Researchers explore:
- Recovery response linked to GH signaling
- Lean tissue support during calorie control phases
- Lower risk of receptor desensitization from shorter action
Previous Research Dosage
10mcg per kg of bodyweight (Example: 90kg × 10mcg = 900mcg) for a max 16 weeks
Administered subcutaneously once or twice daily, often used with a GHRP like Ipamorelin.
Best taken on an empty stomach before bed or post-workout.
Certificate of Analysis
Chemical Structure
Molecular FormulaC₁₄₉H₂₄₆N₄₄O₄₂
Molecular Weight≈3357.9 g/mol
Purity≥99%
AppearanceWhite Lyophilized Powder
StorageStore at -20°C
FormLyophilized Peptide Compound
Key Structural Characteristics
- Short-acting GHRH analog for pulse-frequency studies
- Designed to reduce prolonged GH saturation and improve timing control
- Often paired with GHRPs in endocrine research protocols